日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants

在健康受试者中，一次皮下注射2毫升Mirikizumab与两次皮下注射1毫升Mirikizumab具有生物等效性。

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03422-1
Otani, Yuki; Payne, Christopher D; Loftus, Edward V Jr; D'Haens, Geert; Ben Horin, Shomron; Upadhya K, Abhishek; Todd, Kristin; Pellanda, Paola; Shi, Galen; Zhang, Xin
发表日期：2026
文献求助 收藏

Dominance of conjunctiva-associated lymphoid tissue in the feline ocular immune system, with identification of lacrimal duct-associated lymphoid tissue.

猫眼免疫系统中结膜相关淋巴组织占主导地位，并鉴定出泪管相关淋巴组织。

期刊:Journal of Veterinary Medical Science
影响因子:1.1
doi:10.1292/jvms.25-0433
Hiraishi Masaya, Namba Takashi, Otani Yuki, Kira Shunnosuke, Ichii Osamu
Feline
免疫/内分泌
发表日期：2026
文献求助 收藏

Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials

用于皮下注射的原研药和无柠檬酸盐米利珠单抗制剂的药代动力学可比性和安全性：三项临床试验的结果

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03158-y
Otani, Yuki; Feagan, Brian G; D'Haens, Geert R; Escobar, Rodrigo; Morris, Nathan J; Payne, Christopher D; Ugolini Lopes, Michelle; Zhang, Xin
发表日期：2025
文献求助 收藏

Pharmacokinetic Bridging Between an Autoinjector and a Prefilled Syringe Following Subcutaneous Administration of Mirikizumab in Healthy Participants

在健康受试者中皮下注射米利珠单抗后，自动注射器与预充式注射器之间的药代动力学桥接

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03335-z
Zhang, Xin; Otani, Yuki; Payne, Christopher D; Morris, Nathan J; Chua, Laiyi; Escobar, Rodrigo; Wang, Sihe; Shi, Galen
发表日期：2025
文献求助 收藏

Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis

米利珠单抗在中重度溃疡性结肠炎患儿中的药代动力学和暴露-反应关系

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13286
Otani, Yuki; Chua, Laiyi; Komocsar, Wendy J; Larkin, Amy; Johns, Jordan; Zhang, Xin
结肠炎
肠炎
发表日期：2025
文献求助 收藏

Mirikizumab Pharmacokinetics and Exposure-Response in Patients With Moderately-To-Severely Active Crohn's Disease: Results From Two Randomized Studies

中重度活动性克罗恩病患者中米利珠单抗的药代动力学和暴露-反应关系：两项随机研究的结果

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70320
Chua, Laiyi; Otani, Yuki; Lin, Zhantao; Friedrich, Stuart; Durand, Frederick; Zhang, Xin Cindy
克罗恩病
发表日期：2025
文献求助 收藏

Cross-cultural variation in understanding of animal welfare principles and animal management practices among veterinary and animal welfare professionals in the UK and Japan

英国和日本兽医及动物福利专业人员对动物福利原则和动物管理实践的理解存在跨文化差异

期刊:
影响因子:
doi:10.1017/awf.2025.10026
Otani, Yuki; Kanamori, Mariko; Kato, Hiromi; Dwyer, Cathy M
发表日期：2025
文献求助 收藏

Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma

Myc 上调 Ggct、γ-谷氨酰环化转移酶促进 p53 缺陷型骨肉瘤的发展

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.16255
Tomoya Ueno, Shohei Otani, Yuki Date, Yu Katsuma, Yuma Nagayoshi, Tomoko Ito, Hiromi Ii, Susumu Kageyama, Susumu Nakata, Kosei Ito
肿瘤
骨肉瘤
发表日期：2024
文献求助 收藏

Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone

建立血清M蛋白反应模型，用于早期检测接受硼替佐米、来那度胺和地塞米松治疗的多发性骨髓瘤患者的生化复发

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13225
Otani, Yuki; Zhao, Yunqi; Wang, Guanyu; Labotka, Richard; Rogge, Mark; Gupta, Neeraj; Vakilynejad, Majid; Bottino, Dean; Tanigawara, Yusuke
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Species-specific histological characterizations of renal tubules and collecting ducts in the kidneys of cats and dogs

猫和狗肾脏肾小管和集合管的物种特异性组织学特征

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0306479
Kira, Shunnosuke; Namba, Takashi; Hiraishi, Masaya; Nakamura, Teppei; Otani, Yuki; Kon, Yasuhiro; Ichii, Osamu
发表日期：2024
文献求助 收藏